Dntox
Biotech · Duesseldorf, DE
Human-cell-based test system modelling brain development for animal-free chemical testing
Funding history
| Date | Round | Amount |
|---|
| Jun 2023 | Seed Duesseldorf biotech Dntox raised EUR 1.5M from HTGF, Bool Capital, AQAL Capital and angels for animal-free toxicity testing. | $1.6M |
Investors
AQAL CapitalBool CapitalHigh-Tech Gruenderfonds
Similar companies in Biotech
Explore funding flow on EquityFlow →